Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 568

1.

Nomograms to predict naming decline after temporal lobe surgery in adults with epilepsy.

Busch RM, Hogue O, Kattan MW, Hamberger M, Drane DL, Hermann B, Kim M, Ferguson L, Bingaman W, Gonzalez-Martinez J, Najm IM, Jehi L.

Neurology. 2018 Nov 7. pii: 10.1212/WNL.0000000000006629. doi: 10.1212/WNL.0000000000006629. [Epub ahead of print]

PMID:
30404781
2.

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium.

Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, van der Linden W, Nieboer D, Bangma CH, Frydenberg M, Rannikko A, Lee LS, Gnanapragasam VJ, Kattan MW; Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium.

Eur Urol. 2018 Oct 29. pii: S0302-2838(18)30813-3. doi: 10.1016/j.eururo.2018.10.025. [Epub ahead of print]

PMID:
30385049
3.

Predicting Current Glycated Hemoglobin Values in Adults: Development of an Algorithm From the Electronic Health Record.

Wells BJ, Lenoir KM, Diaz-Garelli JF, Futrell W, Lockerman E, Pantalone KM, Kattan MW.

JMIR Med Inform. 2018 Oct 22;6(4):e10780. doi: 10.2196/10780.

4.

Editorial Comment.

Kattan MW.

J Urol. 2018 Sep 21. pii: S0022-5347(18)43905-5. doi: 10.1016/j.juro.2018.06.103. [Epub ahead of print] No abstract available.

PMID:
30243814
5.

Use of Visual Decision Aids in Physician-Patient Communication: A Pilot Investigation.

Mercer MB, Rose SL, Talerico C, Wells BJ, Manne M, Vakharia N, Jolly S, Milinovich A, Bauman J, Kattan MW.

J Patient Exp. 2018 Sep;5(3):167-176. doi: 10.1177/2374373517746177. Epub 2017 Dec 14.

6.

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort.

Karnes RJ, MacKintosh FR, Morrell CH, Rawson L, Sprenkle PC, Kattan MW, Colicchia M, Neville TB.

Front Oncol. 2018 Aug 6;8:296. doi: 10.3389/fonc.2018.00296. eCollection 2018.

7.

Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care.

Misra-Hebert AD, Hom G, Klein EA, Bauman JM, Gupta N, Ji X, Stephenson AJ, Jones JS, Kattan MW.

Front Oncol. 2018 Jun 28;8:238. doi: 10.3389/fonc.2018.00238. eCollection 2018.

8.

Models for Predicting Recurrence, Complications, and Health Status in Women After Pelvic Organ Prolapse Surgery.

Jelovsek JE, Chagin K, Lukacz ES, Nolen TL, Shepherd JP, Barber MD, Sung V, Brubaker L, Norton PA, Rahn DD, Smith AL, Ballard A, Jeppson P, Meikle SF, Kattan MW; NICHD Pelvic Floor Disorders Network.

Obstet Gynecol. 2018 Aug;132(2):298-309. doi: 10.1097/AOG.0000000000002750.

PMID:
29995735
9.

Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer.

Thomas HR, Chen MH, D'Amico AV, Bennett CL, Kattan MW, Sartor O, Stein K, Nguyen PL.

Clin Genitourin Cancer. 2018 Aug;16(4):313-317. doi: 10.1016/j.clgc.2018.05.007. Epub 2018 Jun 1.

PMID:
29866496
10.

Targets without tolerances: improper evaluation of medical personnel.

Butler RS, Johnston D, Kattan MW.

Ann Transl Med. 2018 Apr;6(8):149. doi: 10.21037/atm.2018.03.35.

11.

Prostate Cancer Screening-A New Recommendation for Meaningful Physician-Patient Conversations.

Misra-Hebert AD, Kattan MW.

JAMA Oncol. 2018 Aug 1;4(8):1049-1050. doi: 10.1001/jamaoncol.2018.1492. No abstract available.

PMID:
29801021
12.

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.

Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, Vickers AJ.

Eur Urol. 2018 Aug;74(2):197-203. doi: 10.1016/j.eururo.2018.05.003. Epub 2018 May 16.

PMID:
29778349
13.

Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set.

Pantalone KM, Misra-Hebert AD, Hobbs TM, Ji X, Kong SX, Milinovich A, Weng W, Bauman J, Ganguly R, Burguera B, Kattan MW, Zimmerman RS.

Diabetes Care. 2018 Jul;41(7):e113-e114. doi: 10.2337/dc18-0116. Epub 2018 Apr 20. No abstract available.

PMID:
29678811
14.

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease.

Pantalone KM, Misra-Hebert AD, Hobbs TM, Ji X, Kong SX, Milinovich A, Weng W, Bauman J, Ganguly R, Burguera B, Kattan MW, Zimmerman RS.

Cardiovasc Diabetol. 2018 Apr 10;17(1):54. doi: 10.1186/s12933-018-0699-7.

15.

Tutorial: development of an online risk calculator platform.

Ji X, Kattan MW.

Ann Transl Med. 2018 Feb;6(3):46. doi: 10.21037/atm.2017.11.37.

16.

Extracting and utilizing electronic health data from Epic for research.

Milinovich A, Kattan MW.

Ann Transl Med. 2018 Feb;6(3):42. doi: 10.21037/atm.2018.01.13.

17.

External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.

Williams BA, Chagin KM, Bash LD, Boden WE, Duval S, Fowkes FGR, Mahaffey KW, Patel MD, D'Agostino RB, Peterson ED, Kattan MW, Bhatt DL, Bonaca MP.

Atherosclerosis. 2018 May;272:80-86. doi: 10.1016/j.atherosclerosis.2018.03.026. Epub 2018 Mar 16.

PMID:
29579671
18.

Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015.

Misra-Hebert AD, Pantalone KM, Ji X, Milinovich A, Dey T, Chagin KM, Bauman JM, Kattan MW, Zimmerman RS.

Diabetes Care. 2018 Jun;41(6):1164-1171. doi: 10.2337/dc17-1834. Epub 2018 Mar 16.

PMID:
29549082
19.

Ten-Year Outcomes and Risk Factors After Anterior Cruciate Ligament Reconstruction: A MOON Longitudinal Prospective Cohort Study.

MOON Knee Group, Spindler KP, Huston LJ, Chagin KM, Kattan MW, Reinke EK, Amendola A, Andrish JT, Brophy RH, Cox CL, Dunn WR, Flanigan DC, Jones MH, Kaeding CC, Magnussen RA, Marx RG, Matava MJ, McCarty EC, Parker RD, Pedroza AD, Vidal AF, Wolcott ML, Wolf BR, Wright RW.

Am J Sports Med. 2018 Mar;46(4):815-825. doi: 10.1177/0363546517749850.

PMID:
29543512
20.

The c-index is not proper for the evaluation of $t$-year predicted risks.

Blanche P, Kattan MW, Gerds TA.

Biostatistics. 2018 Feb 16. doi: 10.1093/biostatistics/kxy006. [Epub ahead of print]

PMID:
29462286
21.

Prostate cancer: Numeracy and understanding of risk reduction of PSA screening.

Subramanian V, Kattan MW.

Nat Rev Urol. 2018 Apr;15(4):208-209. doi: 10.1038/nrurol.2018.21. Epub 2018 Feb 20. No abstract available.

PMID:
29460924
22.

Validation of nomograms for overall survival, cancer-specific survival, and recurrence in carcinoma of the major salivary glands.

Hay A, Migliacci J, Zanoni DK, Patel S, Yu C, Kattan MW, Ganly I.

Head Neck. 2018 May;40(5):1008-1015. doi: 10.1002/hed.25079. Epub 2018 Feb 1.

PMID:
29389040
23.

Next-generation prostate cancer risk calculator for primary care physicians.

Nam RK, Satkunavisam R, Chin JL, Izawa J, Trachtenberg J, Rendon R, Bell D, Singal R, Sherman C, Sugar L, Chagin K, Kattan MW.

Can Urol Assoc J. 2018 Feb;12(2):E64-E70. doi: 10.5489/cuaj.4696. Epub 2017 Dec 1.

24.

Predicting the cure rate of breast cancer using a new regression model with four regression structures.

Ramires TG, Cordeiro GM, Kattan MW, Hens N, Ortega EM.

Stat Methods Med Res. 2018 Nov;27(11):3207-3223. doi: 10.1177/0962280217695344. Epub 2017 Feb 23.

PMID:
29298615
25.

Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure.

Xanthopoulos A, Tryposkiadis K, Giamouzis G, Konstantinou D, Giannakoulas G, Karvounis H, Kattan MW, Skoularigis J, Parissis J, Starling RC, Triposkiadis F.

Eur J Heart Fail. 2018 Mar;20(3):614-616. doi: 10.1002/ejhf.1132. Epub 2017 Dec 22. No abstract available.

PMID:
29271552
26.

Nomogram for survival analysis in the presence of competing risks.

Zhang Z, Geskus RB, Kattan MW, Zhang H, Liu T.

Ann Transl Med. 2017 Oct;5(20):403. doi: 10.21037/atm.2017.07.27.

27.

Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system.

Pantalone KM, Hobbs TM, Chagin KM, Kong SX, Wells BJ, Kattan MW, Bouchard J, Sakurada B, Milinovich A, Weng W, Bauman J, Misra-Hebert AD, Zimmerman RS, Burguera B.

BMJ Open. 2017 Nov 16;7(11):e017583. doi: 10.1136/bmjopen-2017-017583.

28.

Predicting risk of pelvic floor disorders 12 and 20 years after delivery.

Jelovsek JE, Chagin K, Gyhagen M, Hagen S, Wilson D, Kattan MW, Elders A, Barber MD, Areskoug B, MacArthur C, Milsom I.

Am J Obstet Gynecol. 2018 Feb;218(2):222.e1-222.e19. doi: 10.1016/j.ajog.2017.10.014. Epub 2017 Oct 19.

PMID:
29056536
29.

Effect of glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes.

Pantalone KM, Misra-Hebert AD, Hobbs TM, Wells BJ, Kong SX, Chagin K, Dey T, Milinovich A, Weng W, Bauman JM, Burguera B, Zimmerman RS, Kattan MW.

J Diabetes. 2018 Mar;10(3):192-199. doi: 10.1111/1753-0407.12613. Epub 2017 Nov 27.

PMID:
28976724
30.

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.

Welsh P, Kou L, Yu C, Anand I, van Veldhuisen DJ, Maggioni AP, Desai AS, Solomon SD, Pfeffer MA, Cheng S, Gullestad L, Aukrust P, Ueland T, Swedberg K, Young JB, Kattan MW, Sattar N, McMurray JJV.

Eur J Heart Fail. 2018 Feb;20(2):268-277. doi: 10.1002/ejhf.988. Epub 2017 Sep 27.

PMID:
28960777
31.

Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.

Lee BH, Feifer A, Feuerstein MA, Benfante NE, Kou L, Yu C, Kattan MW, Russo P.

Eur Urol Focus. 2018 Jan;4(1):100-105. doi: 10.1016/j.euf.2016.07.006. Epub 2016 Jul 28.

PMID:
28753780
32.

Response to Kerr et al.

Kattan MW, Gerds TA.

Clin Trials. 2017 Dec;14(6):661. doi: 10.1177/1740774517722142. Epub 2017 Jul 26. No abstract available.

PMID:
28743189
33.

Assessment of a Person-Level Risk Calculator to Predict New-Onset Bipolar Spectrum Disorder in Youth at Familial Risk.

Hafeman DM, Merranko J, Goldstein TR, Axelson D, Goldstein BI, Monk K, Hickey MB, Sakolsky D, Diler R, Iyengar S, Brent DA, Kupfer DJ, Kattan MW, Birmaher B.

JAMA Psychiatry. 2017 Aug 1;74(8):841-847. doi: 10.1001/jamapsychiatry.2017.1763.

34.

Drawing Nomograms with R: applications to categorical outcome and survival data.

Zhang Z, Kattan MW.

Ann Transl Med. 2017 May;5(10):211. doi: 10.21037/atm.2017.04.01.

35.

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS.

Neuro Oncol. 2017 May 1;19(5):669-677. doi: 10.1093/neuonc/now208.

36.

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223.

Sartor O, Coleman RE, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Vogelzang NJ, Bruland Ø, Kobina S, Wilhelm S, Xu L, Shan M, Kattan MW, Parker C.

Ann Oncol. 2017 May 1;28(5):1090-1097. doi: 10.1093/annonc/mdx044.

37.

Association of glucagon-like peptide-1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system.

Zimmerman RS, Hobbs TM, Wells BJ, Kong SX, Kattan MW, Bouchard J, Chagin KM, Yu C, Sakurada B, Milinovich A, Weng W, Bauman JM, Pantalone KM.

Diabetes Obes Metab. 2017 Nov;19(11):1555-1561. doi: 10.1111/dom.12969. Epub 2017 Jul 5.

PMID:
28407414
38.

Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Buyyounouski MK, Choyke PL, McKenney JK, Sartor O, Sandler HM, Amin MB, Kattan MW, Lin DW.

CA Cancer J Clin. 2017 May 6;67(3):245-253. doi: 10.3322/caac.21391. Epub 2017 Feb 21.

39.

Comment on: Decisional Conflict, Regret, and the Burden of Rational Decision Making.

Misra-Hebert AD, Kattan MW.

Med Decis Making. 2017 May;37(4):E360-E361. doi: 10.1177/0272989X17691759. Epub 2017 Feb 15. No abstract available.

PMID:
28199177
40.

Prostate cancer screening practices in a large, integrated health system: 2007-2014.

Misra-Hebert AD, Hu B, Klein EA, Stephenson A, Taksler GB, Kattan MW, Rothberg MB.

BJU Int. 2017 Aug;120(2):257-264. doi: 10.1111/bju.13793. Epub 2017 Feb 26.

41.

Editorial Comment.

Kattan MW.

Urology. 2017 Apr;102:3. doi: 10.1016/j.urology.2016.10.050. Epub 2016 Dec 21. No abstract available.

PMID:
28012662
42.

A closed testing procedure to select an appropriate method for updating prediction models.

Vergouwe Y, Nieboer D, Oostenbrink R, Debray TPA, Murray GD, Kattan MW, Koffijberg H, Moons KGM, Steyerberg EW.

Stat Med. 2017 Dec 10;36(28):4529-4539. doi: 10.1002/sim.7179. Epub 2016 Nov 28.

PMID:
27891652
43.

Modeling Individual Patient Preferences for Colorectal Cancer Screening Based on Their Tolerance for Complications Risk.

Taksler GB, Perzynski AT, Kattan MW.

Med Decis Making. 2017 Apr;37(3):204-215. doi: 10.1177/0272989X16679161. Epub 2016 Nov 23.

44.

Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter.

Misra-Hebert AD, Kattan MW.

Front Oncol. 2016 Nov 4;6:235. eCollection 2016. No abstract available.

45.

Validation of the Kattan Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy.

Ondracek RP, Kattan MW, Murekeyisoni C, Yu C, Kauffman EC, Marshall JR, Mohler JL.

J Natl Compr Canc Netw. 2016 Nov;14(11):1395-1401.

46.

Predicting Prostate Cancer Recurrence After Radical Prostatectomy.

Jeffers A, Sochat V, Kattan MW, Yu C, Melcon E, Yamoah K, Rebbeck TR, Whittemore AS.

Prostate. 2017 Feb;77(3):291-298. doi: 10.1002/pros.23268. Epub 2016 Oct 24. Erratum in: Prostate. 2017 Jun;77(8):934.

47.

Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.

Pisansky TM, Agrawal S, Hamstra DA, Koontz BF, Liauw SL, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ, Tendulkar RD.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1046-1053. doi: 10.1016/j.ijrobp.2016.08.043. Epub 2016 Sep 3.

PMID:
27745980
48.

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.

Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ.

J Clin Oncol. 2016 Oct 20;34(30):3648-3654. doi: 10.1200/JCO.2016.67.9647.

PMID:
27528718
49.

Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.

Pantalone KM, Wells BJ, Chagin KM, Ejzykowicz F, Yu C, Milinovich A, Bauman JM, Kattan MW, Rajpathak S, Zimmerman RS.

Diabetes Care. 2016 Sep;39(9):1527-34. doi: 10.2337/dc16-0227. Epub 2016 Aug 12.

PMID:
27519447
50.

On Risk Estimation versus Risk Stratification in Early Prostate Cancer.

Carlsson SV, Kattan MW.

PLoS Med. 2016 Aug 2;13(8):e1002100. doi: 10.1371/journal.pmed.1002100. eCollection 2016 Aug.

Supplemental Content

Loading ...
Support Center